Main menu button

News

Analysis, CLS: Important steps in the right direction
29 maj 2017
Analysis, CLS: Important steps in the right direction
Equity Research
Analysis, Episurf: New cash for the future
29 maj 2017
Analysis, Episurf: New cash for the future
Equity Research
Analysis, Genovis: New launch in focus
23 maj 2017
Analysis, Genovis: New launch in focus
Equity Research
Analysis, Fastator: Too low growth in Offentliga Hus?
22 maj 2017
Analysis, Fastator: Too low growth in Offentliga Hus?
Equity Research
Analysis, ChemoTec: On the edge to a large market
22 maj 2017
Analysis, ChemoTec: On the edge to a large market
Equity Research
Analysis, VA Automotive: Increasing costs squeezes Q1 results
19 maj 2017
Analysis, VA Automotive: Increasing costs squeezes Q1 results
Equity Research
Analysis, Hanza: Room for improvement this year
19 maj 2017
Analysis, Hanza: Room for improvement this year
Equity Research
Analysis Precise Biometrics: High costs starts the new year
17 maj 2017
Analysis Precise Biometrics: High costs starts the new year
Equity Research
Analysis, Kontigo Care: Rising sales
17 maj 2017
Analysis, Kontigo Care: Rising sales
Equity Research
Analysis, Cherry: Growth contiues in 2017
16 maj 2017
Analysis, Cherry: Growth contiues in 2017
Equity Research
Analysis, MultiDocker: High activity in slow season
16 maj 2017
Analysis, MultiDocker: High activity in slow season
Equity Research
Analysis, Cortus: Break through and new money
16 maj 2017
Analysis, Cortus: Break through and new money
Equity Research
Analysis, Amasten Holding: 24 procent rebate
15 maj 2017
Analysis, Amasten Holding: 24 procent rebate
Equity Research
Analysis, Oboya: Growth of 25 procent is reasonable...
12 maj 2017
Analysis, Oboya: Growth of 25 procent is reasonable...
Equity Research
Analysis Serneke: Sold building permissions increase profits
04 maj 2017
Analysis Serneke: Sold building permissions increase profits
Equity Research
Analysis, Hedera Group: Growth but below expectations
04 maj 2017
Analysis, Hedera Group: Growth but below expectations
Equity Research
Earnings review: Serneke Q1 2017
04 maj 2017
Earnings review: Serneke Q1 2017
Equity Research
Earnings comment, TargetEveryone Q1 2017
03 maj 2017
Earnings comment, TargetEveryone Q1 2017
Equity Research
Analysis, Kancera: Application filed for clinical trial fas I
03 maj 2017
Analysis, Kancera: Application filed for clinical trial fas I
Equity Research
Analysis, Wilson Therapeutics: Rare potential
02 maj 2017
Analysis, Wilson Therapeutics: Rare potential
Equity Research